JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB141265

Pargyline hydrochloride,Monoamine oxidase (MAO)抑制剂

Pargyline hydrochloride, Monoamine oxidase (MAO) inhibitor

Be the first to review this product! Submit a review

|

(2 Publications)

MW 195.69 Da, Purity >99%. Monoamine oxidase (MAO) inhibitor (IC50 = 0.9 μM). Orally active in vivo.
1 Images
Chemical Structure - Pargyline hydrochloride, Monoamine oxidase (MAO) inhibitor (AB141265)
  • Chemical Structure

Lab

Chemical Structure - Pargyline hydrochloride, Monoamine oxidase (MAO) inhibitor (AB141265)

2D chemical structure image of ab141265, Pargyline hydrochloride, Monoamine oxidase (MAO) inhibitor

关键信息

CAS 号

306-07-0

纯度

>99%

形式

Solid

form

分子量

195.69 Da

分子式

C<sub>1</sub><sub>1</sub>H<sub>1</sub><sub>4</sub>ClN

PubChem

9373

属性

Synthetic

溶解度

Soluble in water to 100 mM

Soluble in ethanol to 100 mM

生化试剂名称

Pargyline hydrochloride

生物学描述

Monoamine oxidase (MAO) inhibitor (IC50 = 0.9 μM). Orally active in vivo.

经典 SMILES

CN(CC#C)CC1=CC=CC=C1.Cl

InChi

InChI=1S/C11H13N.ClH/c1-3-9-12(2)10-11-7-5-4-6-8-11;/h1,4-8H,9-10H2,2H3;1H

InChiKey

BCXCABRDBBWWGY-UHFFFAOYSA-N

IUPAC 名

N-benzyl-N-methylprop-2-yn-1-amine;hydrochloride

性能和储存信息

运输条件
Ambient - Can Ship with Ice
推荐的短期储存条件
-20°C
推荐的长期储存条件
-20°C
储存信息
Store under desiccating conditions|The product can be stored for up to 12 months

Need more advice on solubility, usage and handling? Please visit our our product support page for more details.

|

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

|

Toxic, refer to SDS for further information.

产品实验方案

文献 (2)

Recent publications for all applications. Explore the full list and refine your search

Science advances 10:eadp6301 PubMed39565858

2024

Reduced striatal M4-cholinergic signaling following dopamine loss contributes to parkinsonian and l-DOPA-induced dyskinetic behaviors.

Applications

Unspecified application

Species

Unspecified reactive species

Beatriz E Nielsen,Christopher P Ford

Frontiers in bioengineering and biotechnology 12:1335474 PubMed38328444

2024

Continuous long-range measurement of tonic dopamine with advanced FSCV for pharmacodynamic analysis of levodopa-induced dyskinesia in Parkinson's disease.

Applications

Unspecified application

Species

Unspecified reactive species

Jeongrak Park,Seongtak Kang,Yaebin Lee,Ji-Woong Choi,Yong-Seok Oh
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com